Delhi HC to consider Singh bros-Daiichi case over Ranbaxy on Jan 23

Our Bureau New Delhi | Updated on January 12, 2018 Published on January 17, 2017

The battle between the Singh brothers of Fortis and Japanese pharma company Daiichi Sankyo has reached a stalemate for now.

The Japanese firm had sought a stay on plans by Malvinder and Shivinder Singh to sell over 26 per cent stake in Fortis, a move that has been in the offing for a few months now.

The Delhi High Court, which is considering a case filed by the latter, seeking payment of penalties by the brothers as determined by a Singapore Tribunal, however, has not given relief to Daiichi for now. The next hearing of the case is scheduled on January 23.

The Singapore Tribunal had ordered the Singh brothers to pay $385 million as damages to Daiichi Sankyo, for allegedly hiding crucial information before selling majority stake to the Japanese firm in 2008.

The matter was challenged in the Delhi High Court by the promoters of Fortis, claiming the order could not be enforced in India.

Fortis refused to respond to queries regarding the case as the matter is subjudice.

However, a source close to the developments said, “The board of directors had approved fund raising plans in August last year. This stake sale is a fund raising venture. The High Court has not taken any action against in the matter now, holding the previous verbal assurance as being sufficient.”

The Singh brothers had earlier given a verbal assurance before the court that they have kept aside assets for paying damages once the court gives its final order in the matter. The High Court has not insisted on a written assurance, as demanded by Daiichi Sankyo.

Published on January 17, 2017

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.